Drug · DIN 02306778
INTELENCE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 27, 2008; first marketed March 27, 2008.
- Drug Identification Number (DIN)
- 02306778
- Company (DIN owner)
- Janssen Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Etravirine J05AG04
- Class
- Human
- Record last updated
- June 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ETRAVIRINE | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 27, 2008: NOC 9436New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “intelence”. A notice may cover another product or only some lots: read it to see what it covers.
Other DINs named INTELENCE
- DIN 02375931 · Marketed
- DIN 02396750 · Cancelled Post Market